Lubiprostone Sucampo Pharmaceuticals Takeda Pharmaceutical

被引：0
|
作者：
Winpenny, JP [1 ]
机构：
[1] Univ E Anglia, Sch Med, Biomed Grp, Inst Hlth, Norwich NR4 7TJ, Norfolk, England
来源：
IDRUGS | 2005年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Sucampo Pharmaceuticals Inc and Takeda Pharmaceutical Co Ltd are developing lubiprostone, a ClC-2 chloride channel activator and a bicyclic member of a series of fatty acid compounds, for the potential treatment of a number of gastrointestinal conditions, including constipation, irritable bowel syndrome, postoperative bowel dysfunction and opioid bowel dysfunction.
引用
收藏
页码：416 / 422
页数：7
相关论文
共 50 条
  • [31] Estrogenic activity of pharmaceuticals and pharmaceutical mixtures in a yeast reporter gene system
    Fent, Karl
    Escher, Claudia
    Caminada, Daniel
    REPRODUCTIVE TOXICOLOGY, 2006, 22 (02) : 175 - 185
  • [32] RELAXING RULES FOR PHARMACEUTICALS AND BENEFIT COVERAGE EXPANSION IN KOREA: THE IMPACT ON THE PHARMACEUTICAL EXPENDITURE
    Oh, R.
    Na, Y.
    VALUE IN HEALTH, 2017, 20 (09) : A661 - A661
  • [33] Improving dissolution kinetics of pharmaceuticals by fluidized bed impregnation of active pharmaceutical ingredients
    Grigorov, Plamen I.
    Glasser, Benjamin J.
    Muzzio, Fernando J.
    AICHE JOURNAL, 2016, 62 (12) : 4201 - 4214
  • [34] BIOCHEMICAL BASIS OF PHARMACEUTICAL CHEMISTRY .11. STEREOCHEMICAL ASPECTS OF THE ACTION OF PHARMACEUTICALS
    NUHN, P
    BUGE, A
    PHARMAZIE, 1991, 46 (06): : 474 - 480
  • [35] Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological materials: An updated review
    Manousi, Natalia
    Tzanavaras, Paraskevas D.
    Zacharis, Constantinos K.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 219
  • [36] Synthesis and application of granular mesoporous carbon for removal of pharmaceuticals from pharmaceutical manufacturers
    Kim, Yohan
    Park, Hosik
    Bae, Jiyeol
    Choi, Heechul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [37] Content Analysis of Pamphlets Provided by Pharmaceutical Companies for the Medical Usage of Oncology Pharmaceuticals
    Saito, M.
    Ryushima, Y.
    Yonemori, K.
    Hirakawa, A.
    Nishigaki, R.
    Makino, Y.
    Yokote, N.
    Ando, M.
    Fujiwara, Y.
    Yamamoto, H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S167 - S167
  • [38] APPLICATION OF NIRS TO THE QUANTITY CONTROL OF PHARMACEUTICALS KETOPROFEN ASSAY IN DIFFERENT PHARMACEUTICAL FORMULAS
    CORTI, P
    DREASSI, E
    MURRATZU, C
    CORBINI, G
    BALLERINI, L
    GRAVINA, S
    PHARMACEUTICA ACTA HELVETIAE, 1989, 64 (5-6): : 140 - 145
  • [39] Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures
    Sim, Won-Jin
    Lee, Ji-Woo
    Lee, Eung-Sun
    Shin, Sun-Kyoung
    Hwang, Seung-Ryul
    Oh, Jeong-Eun
    CHEMOSPHERE, 2011, 82 (02) : 179 - 186
  • [40] Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals
    Berninger, Jason P.
    Brooks, Bryan W.
    TOXICOLOGY LETTERS, 2010, 193 (01) : 69 - 78
12345